ME02152B - Nove antigljivične kompozicije - Google Patents
Nove antigljivične kompozicijeInfo
- Publication number
- ME02152B ME02152B MEP-2015-70A MEP201570A ME02152B ME 02152 B ME02152 B ME 02152B ME P201570 A MEP201570 A ME P201570A ME 02152 B ME02152 B ME 02152B
- Authority
- ME
- Montenegro
- Prior art keywords
- preparation according
- amount
- acid
- diol
- allylamine
- Prior art date
Links
- 239000012871 anti-fungal composition Substances 0.000 title 1
- VVJKKWFAADXIJK-UHFFFAOYSA-N allylamine Natural products NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 6
- 150000002009 diols Chemical class 0.000 claims 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 4
- 230000000843 anti-fungal effect Effects 0.000 claims 4
- 229940121375 antifungal agent Drugs 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- 235000014655 lactic acid Nutrition 0.000 claims 3
- 239000004310 lactic acid Substances 0.000 claims 3
- 150000007524 organic acids Chemical class 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims 3
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims 3
- 229960002722 terbinafine Drugs 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- -1 allylamine compound Chemical class 0.000 claims 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims 2
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims 2
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 206010034016 Paronychia Diseases 0.000 claims 1
- DQPBABKTKYNPMH-UHFFFAOYSA-N amino hydrogen sulfate Chemical group NOS(O)(=O)=O DQPBABKTKYNPMH-UHFFFAOYSA-N 0.000 claims 1
- 230000001857 anti-mycotic effect Effects 0.000 claims 1
- 239000002543 antimycotic Substances 0.000 claims 1
- 229960002449 glycine Drugs 0.000 claims 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (13)
1. Farmaceutski preparat za tretman gljivične infekcije nokta koji sadrži alilaminsko jedinjenje kao antimikotik u količini većoj od 5%, kao i organsku kiselinu ili estar, diol i dodatni sredstvo, pri čemu dodatno sredstvo označava aminosirećnu kiselinu, a navedeni farmaceutski preparat je suštinski bez vode.
2. Preparat prema patentnom zahtjevu 1, naznačen time, što je antigljivično alilaminsko jedinjenje rastvoreno u preparatu.
3. Preparat prema patentnim zahtjevima 1 ili 2, naznačen time, što organska kiselina označava mlječnu kiselinu.
4. Preparat prema bilo kom od zahtjeva od 1 do 3, naznačen time, što su organska kiselina ili njen estar prisutni u količini od 5% do 25%.
5. Preparat prema bilo kom od zahteva od 1 do 4, naznačen time, što diol označava diol izabran iz grupe koju čine propandiol, butandiol, pentandiol i heksandiol.
6. Preparat prema bilo kom od zahtjeva od 1 do 5, naznačen time, što je diol prisutan u količini većoj od 50%.
7. Preparat prema bilo kom od zahtjeva od 1 do 6, naznačen time, što alilaminsko antigljivično jedinjenje označava terbinafin.
8. Preparat prema bilo kom od prethodnih patentnih zahtjeva, naznačen time, što je alilaminsko antigljivično jedinjenje prisutno u količini od 5% do 12%.
9. Preparat prema patentnom zahtevu 8, naznačen time, što je alilaminsko antigljivično jedinjenje prisutno u količini od 8% do 11,5%.
10. Preparat prema bilo kom od prethodnih patentnih zahtjeva, naznačen time, što aminosirćetna kiselina označava etilendiamintetrasirćetnu kiselinu (EDTA).
11. Preparat prema patentnom zahtjevu 1 ili 2, naznačen time, što sadrži mlječnu kiselinu u količini od 5% do 25%; diol izabran iz grupe koju čine propandiol, butandiol, pentandiol i heksandiol u količini većoj od 50%; terbinafin u količini od 5% do 12%; i EDTA u količini između 0,03% i 1%.
12. Preparat prema patentnom zahtjevu 1 ili 2, naznačen time, što sadrži od oko 67.5% do oko 84% propandiola, od 8% do 20% mlečne kiseline, od 0.03% do 0,1% EDTA i od 8% do 12% od terbinafina.
13. Farmaceutski preparat prema bilo kom od zahtjeva od 1 do 12 za upotrebu u postupku tretmana gljivične infekcije nokta.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1150107 | 2011-02-11 | ||
| EP12703537.6A EP2672962B1 (en) | 2011-02-11 | 2012-02-10 | Novel antifungal composition |
| PCT/EP2012/052327 WO2012107565A1 (en) | 2011-02-11 | 2012-02-10 | Novel antifungal composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02152B true ME02152B (me) | 2015-10-20 |
Family
ID=45581892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2015-70A ME02152B (me) | 2011-02-11 | 2012-02-10 | Nove antigljivične kompozicije |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US8952070B2 (me) |
| EP (1) | EP2672962B1 (me) |
| JP (1) | JP5883886B2 (me) |
| KR (1) | KR101647545B1 (me) |
| CN (2) | CN103384518B (me) |
| AU (1) | AU2012215383B2 (me) |
| BR (1) | BR112013020456B1 (me) |
| CA (1) | CA2826741C (me) |
| CY (1) | CY1116275T1 (me) |
| DK (1) | DK2672962T3 (me) |
| ES (1) | ES2535827T3 (me) |
| HR (1) | HRP20150507T1 (me) |
| IL (1) | IL227765A (me) |
| ME (1) | ME02152B (me) |
| MX (1) | MX335945B (me) |
| PL (1) | PL2672962T3 (me) |
| PT (1) | PT2672962E (me) |
| RS (1) | RS53982B1 (me) |
| RU (1) | RU2587064C2 (me) |
| SG (1) | SG192615A1 (me) |
| SI (1) | SI2672962T1 (me) |
| SM (1) | SMT201500154B (me) |
| WO (1) | WO2012107565A1 (me) |
| ZA (1) | ZA201305891B (me) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2672962T3 (en) | 2011-02-11 | 2015-04-20 | Moberg Pharma Ab | Novel anti-fungal composition |
| EP3151085B1 (en) * | 2012-08-30 | 2018-07-11 | Huawei Device (Dongguan) Co., Ltd. | Method, apparatus and computer program product for controlling central processing unit |
| US10272054B2 (en) * | 2015-10-07 | 2019-04-30 | Exodos Life Sciences Lp | Topical antifungal compositions |
| US10543276B2 (en) | 2016-08-08 | 2020-01-28 | Marlinz Pharma, LLC | Topical compositions |
| US10206962B1 (en) | 2016-08-08 | 2019-02-19 | Marlinz Pharma, LLC | Method for treating fungal infections in nails |
| EP3292758A1 (en) | 2016-09-07 | 2018-03-14 | Rottapharm S.p.A. | Antimicrobial composition comprising a carboxylic acid and two diols |
| WO2019206389A1 (en) * | 2018-04-27 | 2019-10-31 | Unigroup Aps | Kit of parts for nail fungus |
| US11576920B2 (en) | 2019-03-18 | 2023-02-14 | The Menopause Method, Inc. | Composition and method to aid in hormone replacement therapy |
| IL303476A (en) | 2020-12-08 | 2023-08-01 | Moberg Pharma Ab | Treatment regimen for onychomycosis using allylamine antifungal compositions |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525635A (en) | 1986-02-04 | 1996-06-11 | Moberg; Sven | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
| DE4337945A1 (de) * | 1993-11-06 | 1995-05-11 | Labtec Gmbh | Pflaster zur Behandlung von Nagelmykosen |
| WO1999009997A1 (en) | 1997-08-26 | 1999-03-04 | Board Of Regents, The University Of Texas System | Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections |
| AUPP146598A0 (en) * | 1998-01-21 | 1998-02-12 | Health And Hygiene International Pty Ltd | Fruit and vegetable wash |
| DE19921794A1 (de) | 1999-05-11 | 2000-11-23 | Hexal Ag | Neue pharmazeutische Zusammensetzung |
| US7074392B1 (en) | 2000-03-27 | 2006-07-11 | Taro Pharmaceutical Industries Limited | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections |
| JP4803511B2 (ja) * | 2000-08-25 | 2011-10-26 | 株式会社ポーラファルマ | 抗真菌医薬組成物 |
| US8486426B2 (en) * | 2002-07-29 | 2013-07-16 | Kimberly-Clark Worldwide, Inc. | Methods and compositions for treatment of dermal conditions |
| CA2492976C (en) | 2002-09-05 | 2011-11-01 | Galderma Research & Development, S.N.C. | Solution for ungual and peri-ungual application |
| JP5059408B2 (ja) * | 2004-08-05 | 2012-10-24 | 久光製薬株式会社 | 爪用外用剤 |
| US20060078599A1 (en) * | 2004-10-12 | 2006-04-13 | Mathew Ebmeier | Pharmaceutical composition applicable to body tissue |
| JP4992181B2 (ja) | 2004-12-28 | 2012-08-08 | 大正製薬株式会社 | 外用剤組成物 |
| WO2006103638A2 (en) | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
| GB0511499D0 (en) * | 2005-06-06 | 2005-07-13 | Medpharm Ltd | Topical ungual formulations |
| CN1939539A (zh) * | 2005-09-29 | 2007-04-04 | 瑞士商拜欧伊果公司 | 疣、指甲疾病、及指甲保养用之局部配方 |
| EP1971324A1 (en) | 2006-01-02 | 2008-09-24 | TLT Medical Ltd | Pharmaceutical composition for the treatment of nail diseases |
| WO2007106622A2 (en) * | 2006-02-03 | 2007-09-20 | Carl Lawyer | Fungicidal formulation and method of use |
| WO2007094999A2 (en) * | 2006-02-13 | 2007-08-23 | Stiefel Laboratories, Inc. | Ungual antifungal compositions |
| US20080038219A1 (en) | 2006-08-07 | 2008-02-14 | Calgenex Corporation | Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof |
| AU2007355106A1 (en) * | 2006-11-29 | 2008-12-18 | Foamix Ltd. | Foamable waterless compositions with modulating agents |
| BRPI0807083A2 (pt) | 2007-02-05 | 2015-05-26 | Biophile Corp Ltd | Eficácia aumentada de compostos de fármaco de alilamina |
| US20080261986A1 (en) | 2007-03-30 | 2008-10-23 | Friden Phillip M | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
| WO2009140215A2 (en) | 2008-05-11 | 2009-11-19 | Geraghty, Erin | Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds |
| EP2317993A2 (en) * | 2008-07-23 | 2011-05-11 | Tdt, Ltd | Methods of administering topical antifungal formulations for the treatment of fungal infections |
| US8524258B2 (en) * | 2008-12-22 | 2013-09-03 | Johnson & Johnson Consumer Companies, Inc. | Structured lotions |
| FR2942716B1 (fr) * | 2009-03-06 | 2011-04-15 | Galderma Res & Dev | Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle |
| RU2011150901A (ru) | 2009-08-13 | 2013-09-20 | Моберг Дерма Аб | Композиции и способы лечения грибковой инфекции ногтей |
| JP5829217B2 (ja) * | 2009-12-23 | 2015-12-09 | ヌーボ リサーチ インコーポレイテッドＮｕｖｏ Ｒｅｓｅａｒｃｈ Ｉｎｃ． | 高浸透性テルビナフィン製剤 |
| WO2012017371A1 (en) | 2010-08-02 | 2012-02-09 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clobetasole propionate, terbinafine hydrochloride and a process to make it |
| DK2672962T3 (en) | 2011-02-11 | 2015-04-20 | Moberg Pharma Ab | Novel anti-fungal composition |
-
2012
- 2012-02-10 DK DK12703537T patent/DK2672962T3/en active
- 2012-02-10 RU RU2013136147/15A patent/RU2587064C2/ru active
- 2012-02-10 PL PL12703537T patent/PL2672962T3/pl unknown
- 2012-02-10 WO PCT/EP2012/052327 patent/WO2012107565A1/en not_active Ceased
- 2012-02-10 ES ES12703537.6T patent/ES2535827T3/es active Active
- 2012-02-10 HR HRP20150507TT patent/HRP20150507T1/hr unknown
- 2012-02-10 RS RS20150300A patent/RS53982B1/sr unknown
- 2012-02-10 AU AU2012215383A patent/AU2012215383B2/en active Active
- 2012-02-10 BR BR112013020456A patent/BR112013020456B1/pt active IP Right Grant
- 2012-02-10 JP JP2013552973A patent/JP5883886B2/ja active Active
- 2012-02-10 SG SG2013059274A patent/SG192615A1/en unknown
- 2012-02-10 CN CN201280007874.9A patent/CN103384518B/zh active Active
- 2012-02-10 SI SI201230198T patent/SI2672962T1/sl unknown
- 2012-02-10 US US13/984,657 patent/US8952070B2/en active Active
- 2012-02-10 CN CN201811087157.7A patent/CN109453150A/zh active Pending
- 2012-02-10 MX MX2013009245A patent/MX335945B/es unknown
- 2012-02-10 CA CA2826741A patent/CA2826741C/en active Active
- 2012-02-10 PT PT127035376T patent/PT2672962E/pt unknown
- 2012-02-10 KR KR1020137023067A patent/KR101647545B1/ko active Active
- 2012-02-10 EP EP12703537.6A patent/EP2672962B1/en active Active
- 2012-02-10 ME MEP-2015-70A patent/ME02152B/me unknown
-
2013
- 2013-08-01 IL IL227765A patent/IL227765A/en active IP Right Grant
- 2013-08-06 ZA ZA2013/05891A patent/ZA201305891B/en unknown
-
2014
- 2014-11-06 US US14/534,640 patent/US9561279B2/en active Active
-
2015
- 2015-05-13 CY CY20151100425T patent/CY1116275T1/el unknown
- 2015-06-30 SM SM201500154T patent/SMT201500154B/xx unknown
-
2016
- 2016-12-20 US US15/384,536 patent/US20170258914A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME02152B (me) | Nove antigljivične kompozicije | |
| JP2014508146A5 (me) | ||
| CO6280584A2 (es) | Derivados heterociclicos fungicidas de (tetrazolil-benzilideneamido)-oximetil | |
| NZ708588A (en) | Succinate dehydrogenase inhibitor containing compositions | |
| WO2012082580A3 (en) | Fungicidal azocyclic amides | |
| IN2012DN05233A (me) | ||
| CO6361852A2 (es) | Derivados de hidroximoil-tetrazol fungicidas | |
| BRPI0813044A2 (pt) | "composto, composição fungicida e método para o controle do fungo fitopatogênico de culturas" | |
| ME01518B (me) | Novi pirazol-4-n-alkoksikarboksamidi kao mikrobiocidi | |
| CO6660480A2 (es) | N[(het) arialalquil)] pirazol (tio) carboxamidas y sus analogos heterosustituidos | |
| CO6361849A2 (es) | Derivados de n-cicloalquil-nbifenilmetil-carboxamida fungicidas | |
| UA117454C2 (uk) | Фунгіцидні похідні піразолкарбоксамідів | |
| CO6660482A2 (es) | N-[(het)]ariletil)pirazol](tio) carboximidas y sus análogos heterosustituidos | |
| JP2011105732A5 (me) | ||
| BR112012014737A2 (pt) | calconas como realçador de agentes antimicrobianos | |
| BR112014025932A2 (pt) | Composição aquosa de condicionador de tecido, método de preparação de água de enxágüe e uso de água de enxágüe preparada | |
| ME02147B (me) | Jedinjenje sa topikalnom primjenom za aktinične keratoze | |
| UY33014A (es) | Nuevos compuestos de diazinil-pirazolilo | |
| JP2011181765A5 (me) | ||
| BR112014002958A2 (pt) | "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com piperidinila antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso". | |
| MX2011009093A (es) | Metodo para disolver agentes antimicoticos, y composiciones con una alta concentracion de agentes antimicoticos, apropiado para su aplicacion a las uñas. | |
| JP2014525971A5 (me) | ||
| WO2013004982A3 (fr) | Procédés de traitement cosmétique et kit | |
| WO2011110995A3 (en) | Liquid concentrated fabric softener composition | |
| BRPI0516077A (pt) | composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes |